| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/31/2007 | WO2007061360A2 Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides |
| 05/31/2007 | WO2007061074A1 Novel bisboron compound |
| 05/31/2007 | WO2007061022A1 Mitochondrial function of prohibitin 2 (phb2) |
| 05/31/2007 | WO2007060924A1 PROTECTING AGENT FOR PANCREATIC β-CELL |
| 05/31/2007 | WO2007059591A1 Oral therapeutic compound delivery system |
| 05/31/2007 | WO2007037543A9 Biarylamide derivative |
| 05/31/2007 | WO2007037514A9 Novel application of heparin-binding epidermal growth factor-like growth factor for medical purposes |
| 05/31/2007 | WO2007031785A3 Bisphosphonate formulation |
| 05/31/2007 | WO2007020382A3 Plant-based medicament for the treatment of liver disease |
| 05/31/2007 | WO2007013093A3 Laxative formulation containing a triphala extract |
| 05/31/2007 | WO2007007145A3 Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue |
| 05/31/2007 | WO2007003957A3 Steroidal glycoside compounds as core 2 glcnac- t inhibitors |
| 05/31/2007 | WO2006127900A3 Tl1a in the treatment of disease |
| 05/31/2007 | WO2006116862A9 Method for inhibiting er stress-induced apoptosis |
| 05/31/2007 | WO2006110496A3 Activation of sodium potassium atpase |
| 05/31/2007 | US20070123551 Use of metabotropic glutamarate receptor 5 (mglur5) antagonists for the treatment of gastrointestinal disorders |
| 05/31/2007 | US20070123532 Piperazine derivatives |
| 05/31/2007 | US20070123530 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 05/31/2007 | US20070123521 Cinnamoyl derivatives and use thereof |
| 05/31/2007 | US20070122475 Taste masking composition |
| 05/31/2007 | US20070122427 Delivery of trefoil peptides |
| 05/31/2007 | US20070122394 administering a VEGFR modulating agent that comprises placental growth factor; a growth factor that binds and activates Flt-1 such as PIGF or VEGF-B, an anti-Flt-1 agonistic antibody or a small molecule agonist |
| 05/31/2007 | DE69133083C5 Behandlung und Vorbeugung von erhöhten Lyso-PAF-Spiegel mediierten mentalen Erkrankungen mit PAF-Antagonisten Treatment and prevention mediated by elevated lyso-PAF mirror mental disorders with PAF antagonists |
| 05/31/2007 | DE102006012244A1 New 5-D-fructose dehydrogenase, optionally in combination with invertase, maltase and/or glucose isomerase, useful in therapy or diagnosis of disorders of fructose metabolism, including fructose intolerance |
| 05/31/2007 | DE102005056558A1 Kombinationspräparate enthaltend physiologische Zellmembran-Bestandteile Combination products containing physiological cell membrane components |
| 05/31/2007 | CA2631017A1 Bisboron compounds for use as intracellular calcium concentration increase inhibitors |
| 05/31/2007 | CA2630222A1 Carbamate compounds as 5-ht4 receptor agonists |
| 05/31/2007 | CA2629904A1 Oral therapeutic compound delivery system |
| 05/30/2007 | EP1790983A1 Method of screening compound preventing cells from infection with hepatitis c virus (hcv) |
| 05/30/2007 | EP1790725A2 Proteins named after FCTRX and nucleic acids encoding same |
| 05/30/2007 | EP1790687A2 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 05/30/2007 | EP1790652A1 Polycyclic guanine phosphodiesterase V inhibitors |
| 05/30/2007 | EP1790651A1 A1 adenosine receptor antagonists |
| 05/30/2007 | EP1790644A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/30/2007 | EP1790643A1 Quinuclidine compounds having quaternary ammonium group, it's preparation method and use as blocking agents of acetycholine |
| 05/30/2007 | EP1790352A1 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder |
| 05/30/2007 | EP1790346A2 Use of bile acid or bile salt fatty acid conjugates |
| 05/30/2007 | EP1790234A1 Natural antioxidant additive for feed and drinking water |
| 05/30/2007 | EP1790220A1 Pathologic model animal for non-alcoholic fatty hepatitis |
| 05/30/2007 | EP1789094A1 Bacterial delivery system |
| 05/30/2007 | EP1789068A2 Composition and method for prevention or treatment of stomatits |
| 05/30/2007 | EP1789067A2 Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues |
| 05/30/2007 | EP1789053A2 Method of wound healing using a2b adenosine receptor antagonists |
| 05/30/2007 | EP1789047A2 Treatment of diseases using nalmefene and its analgos |
| 05/30/2007 | EP1789037A1 Gastric therapies and compositions therefor |
| 05/30/2007 | EP1789033A2 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
| 05/30/2007 | EP1496924A4 Treatment of gastroparesis |
| 05/30/2007 | EP1487818B1 Alkylammonium salts of omeprazole and esomeprazole |
| 05/30/2007 | EP1392291B1 Tripeptidyl peptidase inhibitors |
| 05/30/2007 | EP1389109B1 Gastric acid secretion inhibiting composition |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | EP1311663B1 Claudin polypeptides |
| 05/30/2007 | EP1272504B1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 05/30/2007 | EP1177168B1 Caspase inhibitors and the use thereof |
| 05/30/2007 | CN1973030A Dendritic cell obtained by antigen pulsing |
| 05/30/2007 | CN1972923A Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 05/30/2007 | CN1972709A Treatment method of non alcoholic steatotic hepatitis (NASH) |
| 05/30/2007 | CN1972705A Use of sulglicotide for the treatement of mucositis |
| 05/30/2007 | CN1972698A Beta-hydroxy short to medium chain fatty acid polymer |
| 05/30/2007 | CN1972665A Injectable depot compositions and uses thereof |
| 05/30/2007 | CN1970723A Health-care wine and its preparing process |
| 05/30/2007 | CN1970579A High substitution degree carboxymethyl indianbread polysaccharide and its preparation method and uses |
| 05/30/2007 | CN1970531A 4-azo salicylic acid derivative and process for producing the same and uses |
| 05/30/2007 | CN1970083A Solid pharmaceutical formulation of proton pump inhibitor |
| 05/30/2007 | CN1970070A Oral administered formulation for reducing fat and expelling toxins, preparation process and quality control method thereof |
| 05/30/2007 | CN1970061A Ointment for treating gastric disease and preparation process thereof |
| 05/30/2007 | CN1970055A Capsule for treating gastric diseases |
| 05/30/2007 | CN1970049A Prescription of a health-preserving wine and preparation process thereof |
| 05/30/2007 | CN1970041A A Chinese medicinal composition, preparation process and quality control method thereof |
| 05/30/2007 | CN1970031A Chinese medicine for treating fatty liver |
| 05/30/2007 | CN1970025A Chinese medicinal biological agent of 'Liu Wei Di Huang' decoction and preparation process thereof |
| 05/30/2007 | CN1970017A Medicament for treating ulcerative colitis and preparation process thereof |
| 05/30/2007 | CN1970010A Chinese medicinal formulation for treating gastrointestinal disease |
| 05/30/2007 | CN1970002A Method for preparing minipill of 'Xue Fu Zhu Yu' |
| 05/30/2007 | CN1970001A Pharmaceutical composition comprising kurarinone, magnolia vine fruit and ginseng for treating hepatitis |
| 05/30/2007 | CN1969991A Ointment for treating skin ulcer (ulcer-treating capsule) and preparation process thereof |
| 05/30/2007 | CN1969987A Compound injection for treating diarrhea of poultry and livestock and method for preparing same |
| 05/30/2007 | CN1969981A Chinese medicine for treating calculi and preparation process thereof |
| 05/30/2007 | CN1969976A Chinese medicine for treating hepatic fibrosis |
| 05/30/2007 | CN1969975A Formulation for replenishing qi, regenerating blood, tonigying kidney and nourishing face and method for preparing same |
| 05/30/2007 | CN1969973A Chinese medicinal soft capsule for treating stomachache |
| 05/30/2007 | CN1969970A Application of Rununculus Sieboldii Miq in preparation of medicament for treating gallbladder disease and gastrointestinal convulsion |
| 05/30/2007 | CN1969964A Compound oral Chinese medicinal formulation for treating gallbladder diseases |
| 05/30/2007 | CN1969963A Method for extracting medicament effective component for treating hepatitis and medicinal composition thereof |
| 05/30/2007 | CN1969958A Quality control method of an oral formulation for treating viral hepatitis |
| 05/30/2007 | CN1969957A Pharmaceutical composition comprising flavescent sophora root, magnolia vine fruit and astragalus root |
| 05/30/2007 | CN1969956A Extract of Kadsura longepedunculata Finet et Gagnep, preparation process and use thereof |
| 05/30/2007 | CN1969955A Health-preserving capsule of edible fungus, preparation method and use thereof |
| 05/30/2007 | CN1969954A Use of lindley butterflybush root in preparation of medicament for treating acute and chronic gastroenteritis |
| 05/30/2007 | CN1969937A Pharmaceutical composition for treating hepatitis |
| 05/30/2007 | CN1969936A Glochidion puberum (Linn.) Hutch. |
| 05/30/2007 | CN1969935A Dietary formulation for supplementary treatment of hepatitis |
| 05/30/2007 | CN1969931A Chinese medicinal dispersible tablet for treating acute, chronic and persistent hepatitis and liver cancer |
| 05/30/2007 | CN1969924A Pharmaceutical composition of Silibinin and isatis root |
| 05/30/2007 | CN1969922A Compound pharmaceutical composition and preparation process thereof |
| 05/30/2007 | CN1969896A Anti-hepatitis pharmaceutical composition and preparation process thereof |
| 05/30/2007 | CN1969891A Formulation of red rice and preparation process thereof |
| 05/30/2007 | CN1969888A Method for preparing soft capsule of ground bettle |
| 05/30/2007 | CN1969886A Capsule for treating enteritis |
| 05/30/2007 | CN1969876A Lyophilized injection of lentinan and preparation process thereof |